Literature DB >> 56227

Serological and epidemiological considerations of the role of herpes simplex virus type 2 in cervical cancer.

W E Rawls, C H Garfield, P Seth, E Adam.   

Abstract

To assess the possible biological significance of the observations that women with cervical cancer tend to be younger at first intercourse than control women, data from 1823 women were analyzed for the relationship between age at 1st intercourse and number of sex partners. Women who were younger at first intercourse had more sex partners than did women who were older at first intercourse. The interdependence of age at first intercourse and number of sex partners does not exlude the possibility that intercourse at an early age represents a biologically significant event in which the neoplastic process is initiated. However, it is equally possible that younger women at first intercourse may have multiple sex partners and be at greater risk of coming in contact with a putative oncogenic agent later in life. In addition, sera from patients with herpesvirus infections were assayed for cross-reacting and type-specific antibodies. Approximately 80% of the total antibody activity was to the cross-reacting antigen and only 20% was to the type-specific antigens in the sera of patients infected with either type 1 or type 2 virus. Among patients infected with both types of virus, less antibody activity to the type-specific antigens and more antibody activity to the cross-reacting antigens were found. These observations are discussed with respect to case-control seroepidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 56227

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Genital herpetic infection: a family practice perspective.

Authors:  D Lawee
Journal:  Can Fam Physician       Date:  1982-10       Impact factor: 3.275

2.  Recurrent genital herpes among women: symptomatic v. asymptomatic viral shedding.

Authors:  M C Rattray; L Corey; W C Reeves; L A Vontver; K K Holmes
Journal:  Br J Vener Dis       Date:  1978-08

3.  Antibody to Herpesvirus hominis in patients with carcinoma of the cervix.

Authors:  S N Najem; I G Barton; L S Al-Omar; C W Potter
Journal:  Br J Exp Pathol       Date:  1982-10

4.  Comparison of indirect hemagglutination and indirect immunofluorescence tests with microneutralization tests for detection of type-specific Herpesvirus hominis antibody.

Authors:  L D Johnson; D A Fuccillo; H Stalder; M A Oxman; C E Fraser; D L Madden
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

5.  Three cell lines from hamster buccal pouch tumors induced by topical 7,12-dimethylbenz(a)anthracene, alone or in conjunction with herpes simplex virus inoculation.

Authors:  B M Min; K Kim; H M Cherrick; N H Park
Journal:  In Vitro Cell Dev Biol       Date:  1991-02

6.  The association of viruses with urveal melanoma.

Authors:  D M Albert
Journal:  Trans Am Ophthalmol Soc       Date:  1979

7.  Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.

Authors:  T Subramanian; W E Rawls
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

Review 8.  Herpes simplex virus infections of women and their offspring: implications for a developed society.

Authors:  R J Whitley
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

9.  Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison.

Authors:  G E Dale; R M Coleman; J M Best; B B Benetato; N C Drew; S Chinn; A O Papacosta; A J Nahmias
Journal:  Epidemiol Infect       Date:  1988-06       Impact factor: 2.451

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.